Jan. 14, 2025 /Mpelembe Media/ — BAIBYS™, an Israeli startup, announced its CE-marked AI-powered robotic system for autonomous sperm selection in IVF. This system uses AI and machine vision to identify and isolate optimal sperm cells, addressing the growing global issue of male infertility. The technology aims to improve IVF success rates, reduce procedure time, and standardise the sperm selection process. The company is preparing for commercial launch in Europe, with plans for expansion into the USA and Asia. Clinical trials are scheduled for 2025.

The BAIBYS™ system improves IVF success rates and reduces procedure times through its innovative approach to sperm selection. Here’s how:

• Autonomous Sperm Selection: The system uses advanced AI algorithms and machine vision technology to autonomously select ideal sperm cells. This process is carried out at high magnification, adhering to World Health Organization (WHO) criteria.
• Standardisation: By using AI, the system standardises the sperm selection process. This ensures consistency and reduces variability in the selection, which can be a factor in IVF success.
• Speed: The system not only selects but also physically picks up and isolates the ideal cells within minutes. This significantly reduces the time needed for sperm selection compared to traditional methods.
• Improved Outcomes: The system is designed to improve IVF success rates, reduce the occurrence of birth defects, and increase clinic throughput. This is achieved through the precise and efficient selection of optimal sperm candidates.
• Addressing Infertility: The technology specifically addresses the issue of male infertility, which accounts for approximately 50% of all infertility cases globally. By improving sperm selection, it targets a major challenge in fertility treatment.

BAIBYS™ enhances IVF outcomes by automating and standardising the sperm selection process, thus saving time and improving efficiency, while selecting the highest quality sperm.

BAIBYS™ will initially target Europe for commercial deployment of its autonomous sperm selection technology. The company is preparing for commercial deployment across European fertility clinics. Following the European launch, BAIBYS™ intends to expand to the USA and Asia.

BAIBYS™ employs a combination of advanced technologies for its sperm selection process. The key technologies include:

• Artificial intelligence (AI): The system uses AI algorithms to analyse living sperm cells at high magnification. These algorithms are designed to identify and select optimal sperm candidates based on peer-reviewed morphology and motility parameters.
• Machine vision technology: This technology enables the system to “see” and analyse sperm cells at a microscopic level. It works in conjunction with AI to identify ideal sperm based on World Health Organization (WHO) criteria.
• Micro-robotics: The system uses micro-robotics not only to identify but also to physically pick up and isolate the ideal sperm cells. This is done autonomously and efficiently, within minutes.

BAIBYS™ combines AI, machine vision, and micro-robotics to automate and standardise the sperm selection process for IVF, improving the precision, speed, and efficiency of the procedure.